These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 4168936)
1. Alpha-oxidation as an alternative pathway for the degradation of branched-chain fatty acids in man, and its failure in patients with Refsum's disease. Stokke O; Try K; Eldjarn L Biochim Biophys Acta; 1967 Oct; 144(2):271-84. PubMed ID: 4168936 [No Abstract] [Full Text] [Related]
3. Alpha-oxidation of branched chain fatty acids in man and its failure in patients with Refsum's disease showing phytanic acid accumulation. Eldjarn L; Stokke O; Try K Scand J Clin Lab Invest; 1966; 18(6):694-5. PubMed ID: 4163668 [No Abstract] [Full Text] [Related]
4. Studies on the metabolic error in Refsum's disease. Steinberg D; Mize CE; Avigan J; Fales HM; Eldjarn L; Try K; Stokke O; Refsum S J Clin Invest; 1967 Mar; 46(3):313-22. PubMed ID: 4164676 [TBL] [Abstract][Full Text] [Related]
5. Separation and characterization of phytanic acid-containing plasmatriglycerides from a patient with Refsum's disease. Laurell S Biochim Biophys Acta; 1968 Jan; 152(1):75-9. PubMed ID: 4171423 [No Abstract] [Full Text] [Related]
6. Localization of the oxidative defect in phytanic acid degradation in patients with Refsum's disease. Mize CE; Herndon JH; Blass JP; Milne GW; Follansbee C; Laudat P; Steinberg D J Clin Invest; 1969 Jun; 48(6):1033-40. PubMed ID: 4181594 [TBL] [Abstract][Full Text] [Related]
7. The existence of an alternative pathway for the degradation of branch-chained fatty acids, and its failure in heredopathia atactica polyneuritiformis (Refsum's disease). Eldjarn L; Try K; Stokke O Biochim Biophys Acta; 1966 Apr; 116(2):395-7. PubMed ID: 4163203 [No Abstract] [Full Text] [Related]
8. The nature of the metabolic defect in Refsum's disease. Steinberg D; Avigan J; Mize CE; Herndon JH; Fales HM; Milne GW Pathol Eur; 1968; 3(2):450-8. PubMed ID: 4176998 [No Abstract] [Full Text] [Related]
13. Refsum's disease: defective oxidation of phytanic acid in tissue cultures derived from homozygotes and heterozygotes. Herndon JH; Steinberg D; Uhlendorf BW N Engl J Med; 1969 Nov; 281(19):1034-8. PubMed ID: 4188238 [No Abstract] [Full Text] [Related]
14. The fatty acid composition of skin and plasma lipids in Refsum's disease. Reynolds DJ; Marks R; Davies MG; Dykes PJ Clin Chim Acta; 1978 Dec; 90(2):171-7. PubMed ID: 82497 [TBL] [Abstract][Full Text] [Related]
15. Studies on the alpha oxidation of phytanic acid by rat liver mitochondria. Tsai SC; Avigan J; Steinberg D J Biol Chem; 1969 May; 244(10):2682-92. PubMed ID: 4181515 [No Abstract] [Full Text] [Related]
16. Phytanic acid levels in serum and central nervous system in Refsum's disease. Dereux J; Lowenthal A; Mardens Y; Karcher D Pathol Eur; 1968; 3(2):468-73. PubMed ID: 4177000 [No Abstract] [Full Text] [Related]
17. [Biochemical study of Refsum's disease]. Sezille G; Biserte G Pathol Biol (Paris); 1970 May; 18(9):551-8. PubMed ID: 4192793 [No Abstract] [Full Text] [Related]
18. Changes in sterol and phospholipid fatty acid composition in Refsum's disease fibroblasts grown in the presence of phytol. Friedman KJ; Shapiro SS Clin Physiol Biochem; 1985; 3(5):249-56. PubMed ID: 2414050 [TBL] [Abstract][Full Text] [Related]